Lv3
316 积分 2024-08-07 加入
The Evolving Landscape of Antibody–Drug Conjugates: In Depth Analysis of Recent Research Progress
13小时前
待确认
Dozens of new obesity drugs are coming: these are the ones to watch
20天前
已完结
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: a randomized, double-blind, placebo-controlled study
21天前
已完结
266-OR: Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity
21天前
已关闭
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
4个月前
已完结
Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
4个月前
已完结
Diabetes in China part 1: epidemiology and risk factors
4个月前
已完结
Epidemiology, risk factors, and prognostic factors of gliomas
5个月前
已完结
Cancer statistics, 2024
5个月前
已完结
Impact of cyclin dependent kinase 4/6 inhibitors on breast cancer brain metastasis outcomes
5个月前
已完结
皖公网安备34019202002308
